IDH1 and astrocytoma (excluding glioblastoma): In conclusion, we discovered novel targetable mutations in the FGFR glioblastoma subgroup, including FGFR2 alterations occurring during the evolution of a multifocal and unusually aggressive IDH-mutant astrocytoma.